Abstract
Cellular apoptosis and proliferation was analyzed in an in vitro culture system of organotypic human skin explants in the presence or absence of external fixator pins. The effect on the tissues of a mixture of hyaluronic acid and dermatan sulfate (HA + DS) delivered at the skin–pin interface was also studied. After 2 weeks in culture, skin specimens interfaced with fixator pins showed increased keratinocyte apoptosis and proliferation compared to specimens without fixator pins. Simultaneously, a relative reduction of apoptosis and proliferation was observed in specimens treated with the HA + DS mixture, regardless of fixation pin presence. In addition, the HA + DS mixture appeared to help in the preservation of the epidermal basal membrane. It is concluded that in this in vitro model, fixator pins induce keratinocyte apoptosis and hyperproliferation, which are reduced in the presence of the HA + DS mixture. These methods may be useful for a better maintenance of the soft tissue surrounding percutaneous devices in vivo.
Similar content being viewed by others
References
Ågren, U. M., M. Tammi, M. Ryynänen, and R. Tammi. Developmentally programmed expression of hyaluronan in human skin and its appendages. J. Invest. Dermatol. 109:219–224, 1997.
Amagai, M., P. J. Koch, T. Nishikawa, and J. R. Stanley. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J. Invest. Dermatol. 106:351–353, 1996.
Balaz, E. A., and T. C. Laurent. New applications for hyaluronan. In: The Chemistry, Biology and Medical Applications of Hyaluronan and Its Derivatives, edited by T. C. Laurent. Wenner-Gren Symposium, 1998, (72), p. S.325.
Bedoni, M., C. Sforza, C. Dolci, and E. Donetti. Proliferation and differentiation biomarkers in normal human breast skin organotypic cultures. J. Dermatol. Sci. 46:139–142, 2007.
Blanton, R. A., M. D. Coltrera, A. M. Gown, C. L. Halbert, and J. K. McDougall. Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels. Cell Growth Diff. 3:791–802, 1992.
Breitkreutz, D., H. J. Stark, N. Mirancea, P. Tomakidi, H. Steinbauer, and N. E. Fusenig. Integrin and basement membrane normalization in mouse grafts of human keratinocytes—implications for epidermal homeostasis. Differentiation 61:195–209, 1997.
Buntrock, P., K. D. Jentzsch, and G. Heder. Stimulation of wound healing, using brain extract with fibroblast growth factor (FGF) activity. I. Quantitative and biochemical studies into formation of granulation tissue. Exp. Pathol. 21:46–53, 1982.
Campbell, A. A., L. Song, X. S. Li, B. J. Nelson, C. Bottoni, D. E. Brooks, and E. S. DeJong. Development, characterization, and anti-microbial efficacy of hydroxyapatite-chlorhexidine coatings produced by surface-induced mineralization. J. Biomed. Mater. Res. 53:400–407, 2000.
Campo, G. M., A. Avenoso, S. Campo, A. D’Ascola, P. Traina, D. Samà, and A. Calatroni. NF-kB and caspases are involved in the hyaluronan and chondroitin-4-sulphate-exerted antioxidant effect in fibroblast cultures exposed to oxidative stress. J. Appl. Toxicol. 28:509–517, 2008.
Carruthers, J., and A. Carruthers. Hyaluronic acid gel in skin rejuvenation. J. Drugs Dermatol. 5:959–964, 2006.
Dechert, T. A., A. E. Ducale, S. I. Ward, and D. R. Yager. Hyaluronan in human acute and chronic dermal wounds. Wound Repair Regen. 14:252–258, 2006.
Dunphy, J. E., and K. N. Udupa. Chemical and histochemical sequences in the normal healing of wounds. N. Engl. J. Med. 253:847–851, 1955.
El Ghalbzouri, A., M. F. Jonkman, R. Dijkman, and M. Ponec. Basement membrane reconstruction in human skin equivalents is regulated by fibroblasts and/or exogenously activated keratinocytes. J. Invest. Dermatol. 124:79–86, 2005.
Elkayam, O., I. Yaron, I. Shirazi, M. Yaron, and D. Caspi. Serum levels of hyaluronic acid in patients with psoriatic arthritis. Clin. Rheumatol. 19:455–457, 2000.
Engstrom-Laurent, A., N. Feltelius, R. Hallgren, and A. Wasteson. Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells? Ann. Rheum. Dis. 44:614–620, 1985.
Freitas, J. P., P. Filipe, I. Emerit, P. Meunier, C. F. Manso, and F. Guerra Rodrigo. Hyaluronic acid in progressive systemic sclerosis. Dermatology 192:46–49, 1996.
Gallo, R. L., and M. Bernfield. Proteoglycans and their role in wound repair. In: The Molecular and Cellular Biology of Wound Repair, 2nd edn., Chap. 15, edited by R. F. Clark. New York: Plenum Press, 1996.
Gawronska-Kozak, B., M. Bogacki, J. S. Rim, W. T. Monroe, and J. A. Manuel. Scarless skin repair in immunodeficient mice. Wound Repair Regen. 14:265–276, 2006.
Gupta, D., C. H. Tator, and M. S. Shoichet. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials 27:2370–2379, 2006.
Hebda, P. A., C. K. Klingbeil, J. A. Abraham, and J. C. Fiddes. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J. Invest. Dermatol. 95:626–631, 1990.
Jia, C., C. He, G. W. Cherry, B. Carbow, W. Meyer-Ingold, D. Bader, and D. C. West. Hyaluronan, heterogeneity, and healing: the effects of ultrapure hyaluronan of defined molecular size on the repair of full-thickness pig skin wounds. Wound Repair Regen. 3:299–310, 1995.
Kawashima, H., K. Atarashi, M. Hirose, J. Hirose, S. Yamada, K. Sugahara, and M. Miyasaka. Oversulfated chondroitin/dermatan sulfates containing GlcAβ1/IdoAα1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J. Biol. Chem. 277:12921–12930, 2002.
Knowles, N. G., Y. Miyashita, M. L. Usui, A. J. Marshall, A. Pirrone, K. D. Hauch, B. D. Ratner, R. A. Underwood, P. Fleckman, and J. E. Olerud. A model for studying epithelial attachment and morphology at the interface between skin and percutaneous devices. J. Biomed. Mater. Res. A 74:482–488, 2005.
Koshiishi, I., E. Horikoshi, and T. Imanari. Quantification of hyaluronan and chondroitin/dermatan sulfates in the tissue sections on glass slides. Anal. Biochem. 267:222–226, 1999.
Kubo, M., H. Ihn, A. Matsukawa, K. Kikuchi, and K. Tamaki. Dermatomyositis with elevated serum hyaluronate. Clin. Exp. Dermatol. 24:275–278, 1999.
Longaker, M. T., E. S. Chiu, N. S. Adzick, M. Stern, M. R. Harrison, and R. Stern. Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann. Surg. 213:292–296, 1991.
Lundgren, D., and R. Axelsson. Soft-tissue-anchored percutaneous device for long-term intracorporeal access. J. Invest. Surg. 2:17–27, 1989.
Lundin, A., A. Engstrom-Laurent, R. Hallgren, and G. Michaelsson. Circulating hyaluronate in psoriasis. Br. J. Dermatol. 112:663–671, 1985.
Lundin, A., A. Engstrom-Laurent, G. Michaelsson, and A. Tengblad. High levels of hyaluronate in suction blister fluid from active psoriatic lesions. Br. J. Dermatol. 116:335–340, 1987.
Maas-Szabowski, N., H. J. Stark, and N. E. Fusenig. Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J. Invest. Dermatol. 114:1075–1084, 2000.
Mahan, J., D. Seligson, S. L. Henry, P. Hynes, and J. Dobbins. Factors in pin tract infections. Orthopedics 14:305–308, 1991.
Martikainen, A. L., M. Tammi, and R. Tammi. Proteoglycans synthesized by adult human epidermis in whole skin organ culture. J. Invest. Dermatol. 99:623–628, 1992.
McGee, G. S., J. M. Davidson, A. Buckley, A. Sommer, S. C. Woodward, A. M. Aquino, R. Barbour, and A. A. Demetriou. Recombinant basic fibroblast growth factor accelerates wound healing. J. Surg. Res. 45:145–153, 1988.
McKee, C. M., M. B. Penno, M. Cowman, M. D. Burdick, R. M. Strieter, C. Bao, and P. W. Noble. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest. 98:2403–2413, 1996.
Pasonen-Seppanen, S., S. Karvinen, K. Torronen, J. M. Hyttinen, T. Jokela, M. J. Lammi, M. I. Tammi, and R. Tammi. EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation. J. Invest. Dermatol. 120:1038–1044, 2003.
Passi, A., P. Sadeghi, H. Kawamura, S. Anand, N. Sato, L. E. White, V. C. Hascall, and E. V. Maytin. Hyaluronan suppresses epidermal differentiation in organotypic cultures of rat keratinocytes. Exp. Cell Res. 296:123–134, 2004.
Passos, C. O., C. C. Werneck, G. R. Onofre, E. A. Pagani, A. L. Filgueira, and L. C. Silva. Comparative biochemistry of human skin: glycosaminoglycans from different body sites in normal subjects and in patients with localized scleroderma. J. Eur. Acad. Dermatol. Venereol. 17:14–19, 2003.
Penc, S. F., B. Pomahac, T. Winkler, R. A. Dorschner, E. Eriksson, M. Herndon, and R. L. Gallo. Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. J. Biol. Chem. 273:28116–28121, 1998.
Pendergrass, C. J., A. E. Goodship, and G. W. Blunn. Development of a soft tissue seal around bone-anchored transcutaneous amputation prostheses. Biomaterials 27:4183–4191, 2006.
Penneys, N. S., J. E. Fulton, Jr., G. D. Weinstein, and P. Frost. Location of proliferating cells in human epidermis. Arch. Dermatol. 101:323–327, 1970.
Peramo, A., C. L. Marcelo, S. A. Goldstein, and D. C. Martin. Novel organotypic cultures of human skin explants with an implant-tissue biomaterial interface. Ann. Biomed. Eng. 37:401–409, 2009.
Pickup, J. C., F. Hussain, N. D. Evans, and N. Sachedina. In vivo glucose monitoring: the clinical reality and the promise. Biosens. Bioelectron. 20:1897–1902, 2005 (Review).
Resau, J. H., K. Sakamoto, J. R. Cottrell, E. A. Hudson, and S. J. Meltzer. Explant organ culture: a review. Cytotechnology 7:137–149, 1991.
Savage, Jr., C. R., and S. Cohen. Proliferation of corneal epithelium induced by epidermal growth factor. Exp. Eye Res. 15:361–366, 1973.
Shafritz, T. A., L. C. Rosenberg, and I. V. Yannas. Specific effects of glycosaminoglycans in an analog of extracellular matrix that delays wound contraction and induces regeneration. Wound Repair Regen. 2:270–276, 1994.
Sivan, V., M. C. Vozenin-Brotons, Y. Tricaud, J. L. Lefaix, J. M. Cosset, B. Dubray, and M. T. Martin. Altered proliferation and differentiation of human epidermis in cases of skin fibrosis after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 53:385–393, 2002.
Sondergaard, K., L. Heickendorff, L. Risteli, J. Risteli, H. Zachariae, K. Stengaard-Pedersen, and B. Deleuran. Increased levels of type I and III collagen and hyaluronan in scleroderma skin. Br. J. Dermatol. 136:47–53, 1997.
Stern, R. Devising a pathway for hyaluronan catabolism: Are we there yet? Glycobiology 13:105R–115R, 2003.
Stoscheck, C. M., L. B. Nanney, and L. E. King, Jr. Quantitative determination of EGF-R during epidermal wound healing. J. Invest. Dermatol. 99:645–649, 1992.
Svensjo, T., B. Pomahac, F. Yao, J. Slama, and E. Eriksson. Accelerated healing of full-thickness skin wounds in a wet environment. Plast. Reconstr. Surg. 106:602–612, 2000.
Tammi, M. I., A. J. Day, and E. A. Turley. Hyaluronan and homeostasis: a balancing act. J. Biol. Chem. 277:4581–4584, 2002.
Trautmann, A., F. Altznauer, M. Akdis, H. U. Simon, R. Disch, E. B. Brocker, K. Blaser, and C. A. Akdis. The differential fate of cadherins during T-cell-induced keratinocyte apoptosis leads to spongiosis in eczematous dermatitis. J. Invest. Dermatol. 117:927–934, 2001.
Tsuboi, R., and D. B. Rifkin. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J. Exp. Med. 172:245–251, 1990.
Varani, J., S. E. G. Fligiel, L. Schuger, P. Perone, D. R. Inman, C. E. M. Griffiths, and J. J. Voorhees. Effects of all-trans retinoic acid and Ca2+ on human skin in organ culture. Am. J. Pathol. 142:189–198, 1993.
Voinchet, V., P. Vasseur, and J. Kern. Efficacy and safety of hyaluronic acid in the management of acute wounds. Am. J. Clin. Dermatol. 7:353–357, 2006.
Von Recum, A. F. Applications and failure modes of percutaneous devices: a review. J. Biomed. Mater. Res. 18:323–336, 1984.
Wang, C., M. Tammi, and R. Tammi. Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry 98:105–112, 1992.
Wang, T. W., H. C. Wu, Y. C. Huang, J. S. Sun, and F. H. Lin. Biomimetic bilayered gelatin-chondroitin 6 sulfate-hyaluronic acid biopolymer as the scaffold for skin equivalent tissue engineering. Artif. Organs 30:141–149, 2006.
Welss, T., D. A. Basketter, and K. R. Schröder. In vitro skin irritation: facts and future. State of the art review of mechanisms and models. Toxicol. In Vitro 8:231–243, 2004.
Winter, G. D. Transcutaneous implants: reactions of the skin-implant interface. J. Biomed. Mater. Res. 8:99–113, 1974.
Xu, W., D. H. Xu, and A. D. Crocombe. Three-dimensional finite element stress and strain analysis of a transfemoral osseointegration implant. Proc. Inst. Mech. Eng. [H]: J. Eng. Med. 220:661–670, 2006.
Acknowledgments
We thank Harald Eberhart, College of Engineering, University of Michigan, for help with the glass lid design. We thank Marta Dzaman, Morphology Core, University of Michigan for advice on specimen sectioning and staining. This report is presented as part of research efforts within an Army Research Office Multidisciplinary University Research Initiative award on Bio-Integrating Structural and Neural Prosthetic Materials and we gratefully acknowledge the funding provided. Support for this work was also provided by the University of Michigan College of Engineering GAP Funding program.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Sean S. Kohles oversaw the review of this article.
Rights and permissions
About this article
Cite this article
Peramo, A., Marcelo, C.L., Goldstein, S.A. et al. Improved Preservation of the Tissue Surrounding Percutaneous Devices by Hyaluronic Acid and Dermatan Sulfate in a Human Skin Explant Model. Ann Biomed Eng 38, 1098–1110 (2010). https://doi.org/10.1007/s10439-009-9872-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-009-9872-1